Telomerase activation as a possible mechanism of action for psychopharmacological interventions

Drug Discovery Today

Volumn 20, Issue 11, 2015, Pages 1305-1309

  Bersani, Francesco S ^a,b   Lindqvist, Daniel ^a,c   Mellon, Synthia H ^a   Penninx, Brenda W J H ^d   Verhoeven, Josine E ^d   Révész, Dóra ^d   Reus, Victor I ^a   Wolkowitz, Owen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM; NEUROLEPTIC AGENT; TELOMERASE; WNT PROTEIN; PSYCHOTROPIC AGENT;

ANTIDEPRESSANT ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPSYCHOTIC ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; LITHIUM ACTIVITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SEROTONERGIC MODULATION; THERAPY EFFECT; UPREGULATION; WNT BETA CATENIN PATHWAY MODULATION; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; MENTAL DISORDERS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL SURVIVAL; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 84947036673     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.06.016     Document Type: Short Survey

References (33)

1. S.R. Chan, and E.H. Blackburn Telomeres and telomerase Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359 2004 109 121
2. R.M. Cawthon, and et al. Association between telomere length in blood and mortality in people aged 60 years or older Lancet 361 2003 393 395
3. A. Aviv, and et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR Nucleic Acids Res. 39 2011 e134
4. G. Saretzki Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress Curr. Pharm. Des. 20 2014 6386 6403
5. V. Gorbunova, and A. Seluanov Telomerase as a growth-promoting factor Cell Cycle 2 2003 534 537
6. O.M. Wolkowitz, V.I. Reus, and S.H. Mellon Of sound mind and body: depression, disease, and accelerated aging Dialogues Clin. Neurosci. 13 1 2011 25 39
7. D. Lindqvist, and et al. Psychiatric disorders and leukocyte telomere length: underlying mechanisms linking mental illness with cellular aging Neurosci. Biobehav. Rev. 55 2015 333 364
8. K.R. Prowse, and C.W. Greider Developmental and tissue-specific regulation of mouse telomerase and telomere length Proc. Natl. Acad. Sci. U. S. A. 92 1995 4818 4822
9. Q.G. Zhou, and et al. Hippocampal telomerase is involved in the modulation of depressive behaviors J. Neurosci. 31 2011 12258 12269
10. O.M. Wolkowitz, and et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response Mol. Psychiatry 17 2012 164 172
11. N.M. Simon, and et al. Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls Psychoneuroendocrinology 58 2015 9 22
12. Y. Wei, and et al. Telomerase dysregulation in the hippocampus of a rat model of depression. Normalization by lithium Int. J. Neuropsychopharmacol. 2015 10.1093/ijnp/pyv002
13. L. Martinsson, and et al. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres Transl. Psychiatry 3 2013 e261
14. M.G. Soeiro-de-Souza, and et al. Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder Eur. Neuropsychopharmacol. 24 2014 1139 1143
15. B. Porton, and et al. Telomerase levels in schizophrenia: a preliminary study Schizophr. Res. 106 2008 242 247
16. K. Toriumi, and et al. Effect of antipsychotics on telomere length in the hippocampus 29th CINP World Congress of Neuropsychopharmachology 2014 Available at: https://www1.cinp-congress.org/guest/IDbe554a65a40ffd/AbstractView?ABSID=11787
17. W.Y. Yu, and et al. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment J. Psychiatry Neurosci. 33 2008 244 247
18. G. Sani, and et al. The wnt pathway in mood disorders Curr. Neuropharmacol. 10 2012 239 253
19. Y. Zhang, and et al. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/beta-catenin pathway in human cancer J. Biol. Chem. 287 2012 32494 32511
20. G. Saretzki Telomerase, mitochondria and oxidative stress Exp. Gerontol. 44 2009 485 492
21. F. Ng, and et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications Int. J. Neuropsychopharmacol. 11 2008 851 876
22. R.S. Duman, and et al. Regulation of adult neurogenesis by psychotropic drugs and stress J. Pharmacol. Exp. Ther. 299 2001 401 407
23. W. Fu, and et al. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons J. Neurosci. 22 2002 10710 10719
24. C. Niu, and H.K. Yip Neuroprotective signaling mechanisms of telomerase are regulated by brain-derived neurotrophic factor in rat spinal cord motor neurons J. Neuropathol. Exp. Neurol. 70 2011 634 652
25. J.C. Song, and et al. The effect of telomerase reverse transcriptase on 5-HT induced pulmonary artery smooth muscle cells proliferation Zhonghua Xin Xue Guan Bing Za Zhi 34 2006 837 842
26. Y. Kitagishi, and et al. Roles of PI3K/AKT/GSK3/mTOR pathway in cell signaling of mental illnesses Depress. Res. Treat. 2012 2012 752563
27. H.J. Kang, and et al. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity J. Neurosci. 24 2004 1280 1287
28. J. Lee, and et al. TERT promotes cellular and organismal survival independently of telomerase activity Oncogene 27 2008 3754 3760
29. M. Jaskelioff, and et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice Nature 469 2011 102 106
30. L. Zhou, and et al. Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity Biochem. Biophys. Res. Commun. 386 2009 739 743
31. F.C. Ip, and et al. Cycloastragenol is a potent telomerase activator in neuronal cells: implications for depression management Neurosignals 22 2014 52 63
32. O. Wolkowitz, and et al. PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression Psychiatry Res. 232 2015 58 64
33. E.G. Jacobs, and et al. Relationship between leukocyte telomere length, telomerase activity, and hippocampal volume in early aging JAMA Neurol. 71 2014 921 923